+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Tigecycline in treatment of multidrug-resistant Gram-negative bacillus urinary tract infections: a systematic review

Tigecycline in treatment of multidrug-resistant Gram-negative bacillus urinary tract infections: a systematic review

Journal of Antimicrobial ChemoTherapy 69(10): 2606-2610

To review cases of multidrug-resistant (MDR) Gram-negative bacillus urinary tract infections (UTIs) treated with tigecycline and the literature related to this subject. We performed a systematic review of the literature identifying patients with MDR Gram-negative bacillus UTIs treated with tigecycline. Fourteen cases describing treatment of UTIs caused by MDR Gram-negative bacilli with tigecycline are reviewed. Favourable clinical outcomes were noted in 11 of 14 cases. An initial favourable microbiological outcome was noted in 12 cases. Post-treatment cultures in two cases were positive for tigecycline-resistant organisms. The clinical efficacy of tigecycline for treatment of UTIs has not been extensively evaluated. Based on the available literature, tigecycline appears to have efficacy in some patients with MDR Gram-negative bacillus UTIs. Further research in this area is needed to fully elucidate the role of tigecycline in treating such patients.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 056581858

Download citation: RISBibTeXText

PMID: 24879669

DOI: 10.1093/jac/dku189

Related references

An infectious disease and pharmacokinetic perspective on oral antibiotic treatment of uncomplicated urinary tract infections due to multidrug-resistant Gram-negative uropathogens: the importance of urinary antibiotic concentrations and urinary pH. European Journal of Clinical Microbiology & Infectious Diseases 35(4): 521-526, 2016

Colistin versus polymyxin B for the treatment of patients with multidrug-resistant Gram-negative infections: a systematic review and meta-analysis. International Journal of Antimicrobial Agents (): -, 2016

Multidrug-resistant Gram-negative bacilli causing urinary tract infections: clinical considerations. Journal of ChemoTherapy 23(3): 171-174, 2011

Fosfomycin for the treatment of infections caused by multidrug-resistant non-fermenting Gram-negative bacilli: a systematic review of microbiological, animal and clinical studies. International Journal of Antimicrobial Agents 34(2): 111-120, 2009

Predictive factors for multidrug-resistant gram-negative bacteria among hospitalised patients with complicated urinary tract infections. Antimicrobial Resistance and Infection Control 7: 111-111, 2018

Clinical and microbiological outcomes of serious infections with multidrug-resistant gram-negative organisms treated with tigecycline. Clinical Infectious Diseases 46(4): 567-570, 2008

Parenteral polymyxin B use in patients with multidrug-resistant gram-negative bacteremia and urinary tract infections: a retrospective case series. Annals of PharmacoTherapy 42(9): 1177-1187, 2008

Tigecycline treatment experience against multidrug-resistant Acinetobacter baumannii infections: a systematic review and meta-analysis. International Journal of Antimicrobial Agents 47(2): 107-116, 2016

Combination therapy with polymyxin B for the treatment of multidrug-resistant Gram-negative respiratory tract infections. Journal of Antimicrobial ChemoTherapy 54(2): 566-569, 2004

Strategies for hematological malignancies patients with extensively drug- resistant gram negative bacillus: retrospective study of tigecycline- based treatment approach and the preliminary efficacy of increased-dose of tigecycline. Zhonghua Xue Ye Xue Za Zhi 36(9): 785-787, 2016

Multi-drug-resistant Gram-negative bacteria causing urinary tract infections: a review. Journal of ChemoTherapy 29(Sup1): 2-9, 2017

Once-daily tigecycline therapy of multidrug-resistant and non-multidrug-resistant gram-negative bacteremias. Journal of ChemoTherapy 19(2): 232-233, 2007

Global Assessment of the Activity of Tigecycline against Multidrug-Resistant Gram-Negative Pathogens between 2004 and 2014 as Part of the Tigecycline Evaluation and Surveillance Trial. Msphere 2(1), 2017

Risk factors for aquiring multidrug-resistant organisms in urinary tract infections: A systematic literature review. Saudi Pharmaceutical Journal 26(5): 678-684, 2018

Treatment of complicated urinary tract infections with an emphasis on drug-resistant gram-negative uropathogens. Current Infectious Disease Reports 15(2): 109-115, 2013